Showing 301-310 of 351 grants

Title Institution Researcher Program Duration Total Award Amount
Localized delivery of costimulatory inhibitors and tolerogenic stromal cells for targeted immunomodulation in beta cell replacement University of Miami Alice Tomei Cures 01-February-2024 to 31-January-2027 $824.892,00
Insulin dose and vascular complications in T1D: its role beyond insulin resistance and glycemia University of Pittsburgh Rachel Miller Improving Lives 01-July-2026 to 30-June-2029 $749.947,12
New approach for tolerance induction after allogeneic islets transplantation University of Pittsburgh Eric Lagasse Cures 01-September-2026 to 31-August-2027 $249.994,05
Dock2-mediated T cell migration as a targetable shared mechanism in autoimmunity University of Pittsburgh Alok Joglekar Cures 01-September-2025 to 28-February-2027 $149.999,05
Engineered Regulatory T cells for Suppression of Type 1 Diabetes University of Pittsburgh Alok Joglekar Cures 01-August-2026 to 31-July-2028 $187.584,10
Can Addition of Pioglitazone to SGLT2 Inhibitor in Type 1 Diabetic Patients Amplify the Decrease in HbA1c and Mitigate Diabetic Ketoacidosis Risk? University of Texas Health Science Center at San Antonio Muhammad Abdul-Ghani Improving Lives 01-June-2019 to 31-December-2026 $1.573.835,31
Optimization of fast-acting venom insulins as therapeutic candidates for T1D University of Utah Helena Safavi Improving Lives 01-September-2022 to 01-June-2027 $890.372,53
Structural approaches to understand biased insulin signaling and design glucose-binding proteins for smart insulin therapeutics University of Utah Amber Vogel Improving Lives 01-March-2024 to 28-February-2027 $228.995,00
microRNAs as regulators of stem cell differentiation into islet cells University of Washington Vincenzino Cirulli Cures 01-August-2025 to 31-July-2027 $600.000,00
Promoting functional maturation of SC-derived beta-cells by novel Epigenetic regulators University of Washington Vincenzino Cirulli Cures 01-October-2024 to 30-September-2027 $570.000,00